Sri-Sri Tattva NAOQ19 - Anti Viral | Immunity Booster | Treatment for Mild to Moderate Cases of Infe

• Availibility: In Stock
• Categories : Sri Sri Tattva

Our Specification

Sri Sri Tattva NAOQ19 is a polyherbal Ayurvedic medicine clinically tested and approved by the Ministry of Ayush as a supportive drug for mild to moderate cases of viral infections. It combines 19 natural ingredients to support immunity and respiratory health while alleviating symptoms like sore throat and headache. Sri Sri Tattva Sri Sri Tattva +3 Clinical Efficacy and Benefits Clinical studies indicate that Sri Sri Tattva NAOQ19 significantly accelerates recovery when used alongside standard care. National Institutes of Health (NIH) | (.gov) National Institutes of Health (NIH) | (.gov) Faster Recovery: In a double-blind trial, 76% of patients turned RT-PCR negative within 5 days of treatment, compared to 0% in the placebo group. Symptom Management: It provides relief from fever, persistent cough, bronchial irritation, body aches, joint pain, and fatigue. Immune Support: Ingredients like Ashwagandha and Pippali help strengthen natural defenses and improve the activity of natural killer cells. Respiratory Care: Herbs such as Vasaka and Tulasi support clear breathing and help clear mucus from airways.

The formulation contains a potent blend of traditional Ayurvedic herbs: National Institutes of Health (NIH) | (.gov) National Institutes of Health (NIH) | (.gov) +1 Ashwagandha (Withania somnifera): An adaptogen that enhances overall vitality and stress response. Vasaka (Adhatoda vasica): Traditionally used for its expectorant and anti-inflammatory properties in respiratory care. Kalmegha (Andrographis paniculata): Known for antiviral and hepatoprotective properties. Tulasi (Ocimum sanctum): Supports the respiratory system and acts as an antimicrobial agent. Guduchi (Tinospora cordifolia): Acts as an immunomodulator to boost the body's defenses. Fortune Journals Fortune Journals +2 Usage and Safety Information Dosage: For general immunity or as a prophylactic, the recommended dose is 1 tablet twice daily after food. For infected patients, it is often increased to 1 tablet thrice daily after food, or as directed by a physician. Safety Profile: Trials reported no adverse events or changes in vital functional tests. It is generally well-tolerated in adults. Precautions: Not recommended for children under 12 without medical advice. Pregnant or lactating women and individuals with chronic medical conditions should consult a healthcare professional before use.